Corbus Pharmaceuticals Holdings (CRBP) Other Non Operating Income (2013 - 2025)

Corbus Pharmaceuticals Holdings' Other Non Operating Income history runs 13 years deep, the most recent figure standing at -$50000.0 for Q3 2025.

• On a quarterly basis, Other Non Operating Income fell 125.0% year-over-year to -$50000.0 in Q3 2025; TTM through Sep 2025 was $2.5 million, a 47.63% decrease from a year earlier, with the FY2024 full-year figure at $4.1 million, up 51.08% from the prior year.
• Other Non Operating Income retreated to -$50000.0 in Q3 2025 per CRBP's latest filing, from $176000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $12.0 million in Q3 2021 and bottomed at -$267823.0 in Q1 2022.
• The 5-year median for Other Non Operating Income is $126856.0 (2022), against an average of $1.1 million.
• Across the five-year window, Other Non Operating Income jumped 4891.8% in 2021 and tumbled 4363.72% in 2022, its largest moves.
• Year by year, Other Non Operating Income stood at $25716.0 in 2021, then soared by 2663.29% to $710608.0 in 2022, then surged by 190.74% to $2.1 million in 2023, then slumped by 37.32% to $1.3 million in 2024, then plunged by 103.86% to -$50000.0 in 2025.
• Per Business Quant, the three latest CRBP Other Non Operating Income figures stand at -$50000.0 (Q3 2025), $176000.0 (Q2 2025), and $1.1 million (Q1 2025).